Evaluation of the incidence of carboplatin hypersensitivity reactions in cancer patients.

@article{Navo2006EvaluationOT,
  title={Evaluation of the incidence of carboplatin hypersensitivity reactions in cancer patients.},
  author={Marisa A. Navo and Anuradha Kunthur and Martina L Badell and Larry W Coffer and Maurie Markman and Jubilee B Brown and Judith A. Smith},
  journal={Gynecologic oncology},
  year={2006},
  volume={103 2},
  pages={
          608-13
        }
}
OBJECTIVES Although the reported incidence of carboplatin hypersensitivity is low, its occurrence is important to characterize because of potential fatal complications. The purpose of this study was to determine the current incidence of carboplatin hypersensitivity in the ovarian cancer patients compared to other oncology patients and identify potential risk factors that may contribute to development of carboplatin hypersensitivity reactions. METHODS This was a retrospective chart review… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 25 CITATIONS

A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian Cancer.

  • International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

Management of infusion reactions to systemic anticancer therapy: ESMO Clinical Practice Guidelines.

  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

Management of infusion reactions to systemic anticancer therapy: ESMO Clinical Practice Guidelines.

  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND